´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Á¦ 22Â÷ Ãá°èÁ¤±â½ÉÆ÷Áö¾ö ¹× ÃÑȸ : 2024-05-17
±³À°ÀÏÀÚ : 2024-05-17
±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ¼¿ï
±³À°ÁÖÁ¦ : KSMO Á¦ 22Â÷ Ãá°èÁ¤±â½ÉÆ÷Áö¾ö ¹× ÃÑȸ
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ±è¿¹Áö
¿¬¶ôó : 02-735-2857
À̸ÞÀÏ : meetings@ksmo.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í Á¤È¸¿ø 40000¿ø / ÁØȸ¿ø 30000¿ø /ºñȸ¿ø - ±³¼ö/Àü¹®ÀÇ : 50000¿ø / ÀüÀÓÀÇ,Àü°øÀÇ 30000¿ø / ¾÷ü,±âŸ 60000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 09:00~09:40 The critical role of HIMC in the era of cancer immunotherapy Seunghee Kim-schulze(mssm)
±âŸ 05¿ù 17ÀÏ Room 1 09:40~10:00 Chairman's speech for KSMO ¾ÈÁß¹è(¿¬¼¼¾Ïº´¿ø)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 10:10~10:30 AI-Driven Drug Discovery in the LLM Era: Navigating the New Frontiers °Àç¿ì(°í·Á´ëÇб³)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 10:30~10:50 Innovating Care: Advancing Medical Image Segmentation with AI in Oncology ±èÁø¼º(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 10:50~11:10 º´¿ø ¾÷¹«¿Í °Ç° °ü¸®¸¦ À§ÇÑ ÃÊ°Å´ë¾ð¾î ¸ðµ¨ À¯ÇÑÁÖ(³×À̹ö Ŭ¶ó¿ìµå)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 11:10~11:30 ¸ÖƼ¸ð´Þ ÀÇ·á µ¥ÀÌÅ͸¦ ÀÌÇØÇÏ´Â ÀΰøÁö´ÉÀÇ °³¹ß°ú Æò°¡ ÃÖÀ±Àç(KAIST)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 11:40~12:20 Antibody-drug conjugates for Cancer Therapy: From ¡°Magic Bullet¡± to ¡°Biological Missile¡± ÀÓ¿µÇõ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 14:40~15:00 The landscape of bispecific T cell engager in cancer treatment À̽¿ì(Æ÷Ç×°ø´ë)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 15:00~15:20 Rise of Antibody-Drug Conjugates: The Present and Future Á¤Ã¶¿õ(·¹°íÄÍ)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 15:20~15:40 Current status and perspective of CAR-NK therapy ±èŵ·(KRIBB)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 15:40~16:00 Clinical development of novel therapy ±èÇý·Ã(¿¬¼¼¾Ïº´¿ø)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 13:10~13:30 Financial burden: How much it matters and how to relieve? ¾ÈÈñ°æ(°¡Ãµ´ë±æº´¿ø)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 13:30~13:50 Care from whom: Why medical oncologist should be your doctor? ±ÇÁ¤Çý(¼¼Á¾Ãæ³²´ëº´¿ø)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 13:50~14:10 Hospice facilities: Are they adequate or hopeless? °Á¤ÈÆ(°æ»ó´ëº´¿ø)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 12:30~13:10 Global backbone therapy, Osimertinib: Raising the bar for better outcomes in EGFR-mutant NSCLC ¹Ú¼¼ÈÆ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 14:10~14:30 °í°¡ Ç×¾ÏÁ¦ ±Þ¿©Á¤Ã¥ ¹æÇâ ¹ßÁ¦ ¿ÀâÇö(º¸°Çº¹ÁöºÎ)
±³À°½Ã°£ 05¿ù 17ÀÏ Room 1 16:20~17:00 ESMO REAL WORLD DATA AND DIGITAL HEALTH WORKING GROUP Miriam Koopman(UMC Utrecht Cancer Center)